Recent advances in synthesis and surface modification of lanthanide-doped upconversion nanoparticles for biomedical applications

Biotechnol Adv. 2012 Nov-Dec;30(6):1551-61. doi: 10.1016/j.biotechadv.2012.04.009. Epub 2012 Apr 27.

Abstract

Lanthanide (Ln)-doped upconversion nanoparticles (UCNPs) with appropriate surface modification can be used for a wide range of biomedical applications such as bio-detection, cancer therapy, bio-labeling, fluorescence imaging, magnetic resonance imaging and drug delivery. The upconversion phenomenon exhibited by Ln-doped UCNPs renders them tremendous advantages in biological applications over other types of fluorescent materials (e.g., organic dyes, fluorescent proteins, gold nanoparticles, quantum dots, and luminescent transition metal complexes) for: (i) enhanced tissue penetration depths achieved by near-infrared (NIR) excitation; (ii) improved stability against photobleaching, photoblinking and photochemical degradation; (iii) non-photodamaging to DNA/RNA due to lower excitation light energy; (iv) lower cytotoxicity; and (v) higher detection sensitivity. Ln-doped UCNPs are therefore attracting increasing attentions in recent years. In this review, we present recent advances in the synthesis of Ln-doped UCNPs and their surface modification, as well as their emerging applications in biomedicine. The future prospects of Ln-doped UCNPs for biomedical applications are also discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomedical Technology / methods*
  • Drug Delivery Systems
  • Humans
  • Lanthanoid Series Elements / chemical synthesis*
  • Nanoparticles / chemistry*
  • Point-of-Care Systems
  • Surface Properties

Substances

  • Lanthanoid Series Elements